PARP9 and acute promyelocytic leukemia: According to several reports, here we also showed the specific downregulation of PARP-1 and PARP-9 transcripts (Figure 2B), which are known to be overexpressed in AML cells [110,111] and may represent an intriguing target for AML therapy [112] as well as for APL as suggested by the results reported here.